SCHEMBL16057266

SCHEMBL16057266

Cc1c(-c2ccc(C(=O)N3CCOCC3)cc2)ccn(C(=O)O)c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAF1 P21675 3/20 0.49
▸ PDCD1 Q15116 1/20 0.49
▸ CD274 Q9NZQ7 1/20 0.49
▸ HPGD P15428 5/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ PHGDH O43175 1/20 0.47
▸ TSHR P16473 1/20 0.45
▸ BRD9 Q9H8M2 4/20 0.45
▸ BRD4 O60885 2/20 0.45
▸ CECR2 Q9BXF3 2/20 0.45
▸ POLB P06746 1/20 0.44
▸ DNMT1 P26358 1/20 0.44
▸ PTPN7 P35236 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16056811 0.88 HPGD (0.50) HPGDALDH1A1TSHRBRD9BRD4
SCHEMBL14975270 0.75 KDM4E (0.39) PDCD1CD274ALDH1A1KDM4EMAPT
SCHEMBL17194215 0.73 HPGD (0.63) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL10720943 0.72 PHGDH (0.81) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL8150805 0.72 HPGD (0.76) HPGDALDH1A1KDM4EMAPTSMN1; SMN2
SCHEMBL16058025 0.71 MTOR (0.52) PDCD1CD274HPGDALDH1A1KDM4E
SCHEMBL12871 0.71 PHGDH (0.69) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL16057572 0.70 NPC1 (0.53) HPGDALDH1A1SMN1; SMN2TSHRKMT2A
SCHEMBL4696938 0.70 HPGD (0.72) HPGDALDH1A1KDM4EMAPTHTT
SCHEMBL16058367 0.69 DHODH (0.43) ALDH1A1MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 TAF1 4273/4885PDCD1 4689/4885CD274 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback